Afya (AFYA) versus The Competition Critical Analysis

by · The Markets Daily

Afya (NASDAQ:AFYA – Get Free Report) is one of 166 publicly-traded companies in the “Diversified Consumer Services” industry, but how does it weigh in compared to its competitors? We will compare Afya to similar businesses based on the strength of its dividends, institutional ownership, earnings, risk, analyst recommendations, profitability and valuation.

Volatility & Risk

Afya has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Afya’s competitors have a beta of 0.50, indicating that their average stock price is 50% less volatile than the S&P 500.

Earnings and Valuation

This table compares Afya and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross RevenueNet IncomePrice/Earnings Ratio
Afya$662.01 million$134.77 million6.48
Afya Competitors$3.24 billion$219.82 million11.72

Afya’s competitors have higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

88.0% of Afya shares are owned by institutional investors. Comparatively, 48.4% of shares of all “Diversified Consumer Services” companies are owned by institutional investors. 19.8% of shares of all “Diversified Consumer Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Afya and its competitors, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Afya13402.38
Afya Competitors1436343552841972.41

Afya currently has a consensus price target of $15.70, indicating a potential upside of 47.76%. As a group, “Diversified Consumer Services” companies have a potential upside of 57.90%. Given Afya’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Afya has less favorable growth aspects than its competitors.

Dividends

Afya pays an annual dividend of $0.66 per share and has a dividend yield of 6.2%. Afya pays out 40.2% of its earnings in the form of a dividend. As a group, “Diversified Consumer Services” companies pay a dividend yield of 5.8% and pay out 36.3% of their earnings in the form of a dividend.

Profitability

This table compares Afya and its competitors’ net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Afya20.55%17.58%9.09%
Afya Competitors-3.43%-28.34%2.46%

Summary

Afya competitors beat Afya on 10 of the 15 factors compared.

About Afya

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.